IGIM
UTHR icon

I.G. Investment Management’s United Therapeutics UTHR Stock Holding History

I.G. Investment Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-7,804
Closed -$922K – 725
2016
Q3 		$922K Buy
7,804
+1,376
+21% +$165K ﹤0.01% 672
2016
Q2 		$681K Buy
+6,428
New +$717K ﹤0.01% 723

Other funds holding UTHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

I.G. Investment Management's UTHR Position: Q4 2016 in Review

I.G. Investment Management sold out of United Therapeutics (UTHR) in Q4 2016, closing a stake of 7,804 shares — an estimated $922K sold.

I.G. Investment Management first reported a position in UTHR in Q2 2016 and held it in 2 quarters. The position peaked at $922K in Q3 2016. 406 funds tracked by Wall St. Rank hold UTHR as of Q4 2016.

  • I.G. Investment Management reported no remaining United Therapeutics position as of Q4 2016 after selling out during the quarter.
  • I.G. Investment Management sold 7,804 United Therapeutics shares in Q4 2016, an estimated $922K.
  • I.G. Investment Management first reported a position in United Therapeutics in Q2 2016 and held it in 2 quarters.
  • I.G. Investment Management's United Therapeutics position peaked at $922K in Q3 2016.
  • 406 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2016.

Based on I.G. Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.